Maureen P. Martin, M.D.

  • Center for Cancer Research
  • National Cancer Institute


Dr. Martin's research interests involve studies of host genetic effects on complex human diseases including infectious diseases, autoimmune diseases and cancer. Her focus is on genes known to participate in innate and acquired immunity, primarily the killer immunoglobulin-like receptor (KIR) genes and related loci.

Areas of Expertise

Killer Immunoglobulin-like Receptor (KIR)
Human Leukocyte Antigens (HLA)


Selected Publications

Associations between human leukocyte antigen class I variants and the Mycobacterium tuberculosis subtypes causing disease

Salie M, van der Merwe L, Möller M, Daya M, van der Spuy GD, van Helden PD, Martin MP, Gao XJ, Warren RM, Carrington M, Hoal EG.
J Infect Dis. 209: 216-23, 2014. [ Journal Article ]

Immunogenetics of HIV disease

Martin MP, Carrington M.
Immunol Rev. 254: 245-64, 2013. [ Journal Article ]

Recombinant structures expand and contract inter and intragenic diversification at the KIR locus

Pyo CW, Wang R, Vu Q, Cereb N, Yang SY, Duh FM, Wolinsky S, Martin MP, Carrington M, Geraghty DE.
BMC Genomics. 14: 89, 2013. [ Journal Article ]

Diversity of the KIR gene cluster in an urban Brazilian population

Augusto DG, Zehnder-Alves L, Pincerati MR, Martin MP, Carrington M, Petzl-Erler ML.
Immunogenetics. 64: 143-52, 2012. [ Journal Article ]

Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers

Tomescu C, Duh FM, Hoh R, Viviani A, Harvill K, Martin MP, Carrington M, Deeks SG, Montaner LJ.
AIDS. 26: 1869-78, 2012. [ Journal Article ]